JAMDA
February 21, 2018
Showing 21 - 30 of 2872 results
JAMDA
November 23, 2023
The Impact of State Dementia Training Requirements for Nursing Homes on Antipsychotic Medication Use
Nursing home (NH) staff often report not having adequate dementia-specific knowledge to effectively care for these residents. Between 2011 and 2019, 9 states in the United States implemented dementia training requirements for NH staff. This study evaluated whether the state-mandated dementia training for N...
JAMDA
December 27, 2019
Reducing Fluoroquinolone Use and Infections in Community Nursing Homes Through Hospital–Nursing Home CollaborationClostridioides difficileReducing Fluoroquinolone Use and Infections in Community Nursing Homes Through Hospital–Nursing Home Collaborat
Nursing homes (NHs) are an important target for antibiotic stewardship (AS). We describe a collaborative model to reduce infections (CDIs) in NHs through optimization of antibiotic use including a reduction in high-risk antibiotics such as fluoroquinolones.
JAMDA
February 6, 2025
Antipsychotic Use in Older Adults with Dementia: Community and Nursing Facility Trends in Texas, 2015-2020
To assess recent trends in antipsychotic use among older adults with Alzheimer's disease and related dementias (ADRDs) according to their residential status and determine the factors associated with the use of antipsychotics.
Spotlight
July 28, 2025
Third Module of D2D Course Looks at Optimizing Antipsychotic Use
The first two modules in the Drive to Deprescribe (D2D) course—Design Your Deprescribing Intervention and Deprescribing Communication Techniques—have been extremely popular. Based on the initial reaction to the latest module, Optimizing Use of Antipsychotic Medications, PALTmed has another hit on its hands...
JAMDA
November 19, 2021
Mortality Reduction Associated with Coexistent Antithrombotic Use in Nursing Home Residents with COVID-19
Other Event
Jun 23, 2026 11:30 am - Jun 23, 2026 1:30 pm
Antipsychotic Stewardship in SNFs: Project PAUSE, the Updated Long-Stay Metric, Boxed Warnings, and the Consultant Pharmacist’s Essential Role in Regulatory Compliance and Resident-Centered Care
This APEX webinar delivers practical, up-to-date guidance on appropriate antipsychotic management, spotlighting the consultant pharmacist’s leadership role in balancing safety, regulatory requirements, and resident quality of life. Join us for an in-depth exploration of Project PAUSE (Psychoactive Appropriate Use for Safety and Effectiveness), the national coalition — with ASCP as a key convener — that has driven national advocacy for evidence-based antipsychotic use in nursing homes.
Read More
JAMDA
June 27, 2022
Nursing Home Characteristics Associated with High and Low Levels of Antipsychotic, Benzodiazepine, and Opioid Prescribing to Residents with Alzheimer’s Disease and Related Dementias: A Cross-Sectional Analysis
We examined the association between nursing home (NH) characteristics and whether NHs had high or low levels of antipsychotic, benzodiazepine, or opioid prescribing to residents with Alzheimer’s disease and related dementias (ADRD). We then measured the likelihood that NHs who were high (low) prescribers o...
JAMDA
September 18, 2018
Exploring Antipsychotic Prescribing Behaviors for Nursing Home Residents With Dementia: A Qualitative Study
Caution is advised when prescribing antipsychotics to people with dementia. This study explored the determinants of appropriate, evidence-based antipsychotic prescribing behaviors for nursing home residents with dementia, with a view to informing future quality improvement efforts and behavior change inter...
Policy Snapshot
August 18, 2025
CMS Temporarily Pauses Nursing Home Care Compare Updates
The Centers for Medicare & Medicaid Services (CMS) has announced a temporary pause in the monthly updates to the Nursing Home Care Compare Five-Star Rating System. This pause is part of CMS’ transition to a new, cloud-based platform, the Internet Quality Improvement and Evaluation System (iQIES). ...
